Welcome to our dedicated page for Alerian MLP Index ETN SEC filings (Ticker: AMJB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alerian MLP Index ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alerian MLP Index ETN's regulatory disclosures and financial reporting.
JPMorgan Chase & Co. Chief Risk Officer Ashley Bacon reported selling 7,364 shares of JPMorgan common stock on January 16, 2026 at a price of $312.791 per share. Following this transaction, Bacon directly beneficially owns 237,157 shares of JPMorgan common stock.
JPMorgan Chase Financial Company LLC is offering Enhanced Jump Securities with an auto-call feature, linked to the worse performer of the EURO STOXX 50® and S&P 500® indices. Each security has a $1,000 stated principal amount and does not pay periodic interest.
If on the first determination date in February 2027 both indices close at or above their initial levels, the notes are automatically redeemed for at least $1,080, reflecting a return of approximately 8.00% per year. If not called and, at final maturity in January 2028, both indices are at or above 70% of their initial levels, investors receive at least $1,160 per note. If either index finishes below 70%, the payoff falls in line with the decline of the worse-performing index and can be as low as zero, so principal is fully at risk.
The securities are unsecured, unsubordinated obligations of JPMorgan Chase Financial Company LLC, fully and unconditionally guaranteed by JPMorgan Chase & Co. The price to the public is $1,000 per note, with per-note selling commissions of $15.00 and an additional $3.75 fee, and an indicative estimated value of about $937.30 per $1,000 on the trade date.
JPMorgan Chase & Co. common stock is proposed to be sold under a Rule 144 notice. The person for whose account the securities are to be sold listed 3,404 shares of common stock, with an aggregate market value of $1,064,758.00, to be sold through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026. The class is identified as common stock with $1 par value, and the filing notes that 2,696,272,576 shares of this class were outstanding.
The 3,404 shares were acquired on 03/25/2022 from the issuer as a result of awards granted by the issuer and are described as equity compensation. The form includes the standard representation that the person signing does not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.
A shareholder has filed a notice of proposed sale of 2,893 shares of common stock, to be sold on the NYSE through J.P. Morgan Securities LLC. Based on the information provided, the shares have an aggregate market value of 904,889.57 at the time of the notice, compared with 2,696,272,576 shares outstanding for the issuer. The securities were acquired on 01/13/2026 as a result of equity compensation awards granted by the issuer, meaning they were received as part of a compensation program rather than purchased for cash.
A notice under Rule 144 reports a planned sale of 3,487 shares of common stock, with an aggregate market value of $1,090,727.70. The securities are expected to be sold on the NYSE through J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, NY 10017-2014, with an approximate sale date of 01/16/2026.
The shares being sold were acquired on 01/13/2026 as a result of awards granted by the issuer and are described as equity compensation for common stock with $1 par value. The form also includes a representation that the person for whose account the securities are to be sold does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
JPMorgan Chase & Co. (symbol JPM) has a planned insider sale of common stock under Rule 144. A holder has filed to sell 5,732 shares of JPM common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026 and an aggregate market value of $1,792,878.56. The filing states that these 5,732 shares of common stock with $1 par value were acquired on 01/13/2026 as equity compensation from the issuer.
A holder of JPM common stock has filed a notice of proposed sale under Rule 144. The filing covers 3,908 shares of common stock to be sold through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 1222353.41. The issuer had 2,696,272,576 shares outstanding when the notice was prepared, which is a baseline figure. These shares were originally acquired on 01/13/2022 as equity compensation awards from the issuer, with payment also dated 01/13/2022 and described as Equity Compensation.
JPM has filed a notice of proposed sale under Rule 144 for 2,047 shares of common stock, to be sold through J.P. Morgan Securities LLC on the NYSE around 01/16/2026. The filing shows an aggregate market value of $640,295.04 for these shares and notes that 2,696,272,576 shares of the same class were outstanding. The shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer, paid in stock rather than cash.
By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder has filed a Form 144 notice for the planned sale of 8,571 shares of common stock. The shares are expected to be sold on or about 01/16/2026 on the NYSE through J.P. Morgan Securities LLC, with an indicated aggregate market value of $2,680,888.09. The issuer has 2,696,272,576 shares outstanding.
The securities being sold were acquired on 01/13/2026 from the issuer as equity compensation in the form of awards granted by the issuer. By signing the notice, the selling person represents that they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
JPM has a planned sale of 7,364 shares of common stock under Rule 144 through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026. The filing reports an aggregate market value of these shares of $2,303,393.28 and notes that 2,696,272,576 shares of this class were outstanding.
The shares to be sold were acquired on 01/13/2026 as equity compensation awards granted by the issuer, with the consideration described as Equity Compensation.